<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01531686</url>
  </required_header>
  <id_info>
    <org_study_id>2011-02</org_study_id>
    <nct_id>NCT01531686</nct_id>
  </id_info>
  <brief_title>Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route</brief_title>
  <official_title>An Observational Study to Determine the Safety and Effectiveness of Intraosseous Vascular Access for the Delivery of CT Contrast Dye</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vidacare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vidacare Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intraosseous vascular access can be used to effectively and safely deliver contrast dye for
      CT examination.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      intraosseous vascular access in the proximal humerus can be used to delivery contrast dye for
      CT examination.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Slow rate of enrollment
  </why_stopped>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adequate CT image</measure>
    <time_frame>at time of CT examination average time is within 24 hours</time_frame>
    <description>ability to effectively administer the contrast medium needed for the indicated CT examination.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of participants with adverse events within 24 hours of CT exam</measure>
    <time_frame>within 24 hours of CT exam</time_frame>
    <description>incidence of complications assocated with the administration of contrast medium through the intraosseous route.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of participants with adverse events within 30 days of CT exam</measure>
    <time_frame>within 30 days of CT exam</time_frame>
  </primary_outcome>
  <enrollment type="Actual">8</enrollment>
  <condition>Intraosseous Vascular Access Patients Requiring CT Exam</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraosseous delivery of CT contrast dye</intervention_name>
    <description>Delivery of CT contrast through intraosseous vascular access at the proximal humerus for CT examination.</description>
    <other_name>EZ-IO</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients that have received intraosseous vascular access as standard of care and
        require CT examination
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18 years or older

          -  Has received intraosseous vascular access at the proximal humerus insertion site via
             EZ-IO as standard of care

          -  Requires CT examination with contrast media delivery via proximal humerus intraosseous
             catheter, as standard of care

          -  Cognitively and physically able to give written consent to participate in the study

        Exclusion Criteria:

          -  Fracture in target bone, or significant trauma to the site

          -  Excessive tissue and/or absence of adequate anatomical landmarks in target bone

          -  Infection in target area

          -  IO insertion in past 24 hours, prosthetic limb or joint or other significant
             orthopedic procedure in target bone

          -  Allergy to contrast media

          -  Imprisoned

          -  Pregnant

          -  Requires English language translation other than Spanish

          -  Has received IO access with an IO catheter other than the EZ-IO system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Philbeck, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Sponsor Company- Vidacare Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maricopa Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Olive View UCLA Medical Center</name>
      <address>
        <city>Sylmar</city>
        <state>California</state>
        <zip>91342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shands Critical Care Center and Cancer Hospital</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grand Strand Regional Medical</name>
      <address>
        <city>Myrtle Beach</city>
        <state>South Carolina</state>
        <zip>29572</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2012</study_first_submitted>
  <study_first_submitted_qc>February 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2012</study_first_posted>
  <last_update_submitted>December 5, 2016</last_update_submitted>
  <last_update_submitted_qc>December 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intraosseous vascular access</keyword>
  <keyword>CT examination</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

